B-ENT

EMG-guided salpingopharyngeus Botox® injection for palatal myoclonus

1.

Department of Otolaryngology, Head and Neck Surgery, Cathay General Hospital, Taipei, Taiwan

2.

Department of Neurology, Cathay General Hospital, Taipei, Taiwan

3.

Department of Neurology, National Yang-Ming University, Taipei, Taiwan

4.

School of Medicine, Fu Jen Catholic University, Taipei, Taiwan

5.

School of Public Health, China Medical University, Taichung, Taiwan

B-ENT 2013; 9: 67-69
Read: 979 Downloads: 723 Published: 12 February 2020

EMG-guided salpingopharyngeus Botox® injection for palatal myoclonus. Palatal myoclonus (PM) is a rare neurological disorder characterized by involuntary movements of the soft palate musculature causing objective clicking tinnitus. Two forms are recognized as distinct clinical entities, with poorly understood pathogenesis: essential and symptomatic PM. The intrusive nature of the tinnitus prompts patients to seek medical advice. Conventional medical treatments with anxiolytics, antidepressants, and anticonvulsants have limited efficacy in these patients. In this case report, electromyography-guided injection of botulinum toxin type A (Botox; Allergan, Irvine, CA, USA) to the involved salpingopharyngeus and tensor veli palatini yielded satisfactory results with minimal temporary adverse effects.

Files
EISSN 2684-4907